Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1073/pnas.1518553113 http://scihub22266oqcxt.onion/10.1073/pnas.1518553113 C4776531!4776531!26862169     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Proc+Natl+Acad+Sci+U+S+A 2016 ; 113 (8): 2188-93 Nephropedia Template TP {{tp|p=26862169|t=2016. Anoctamin 2 identified as an autoimmune target in multiple sclerosis |pdf=|usr=}}{{26862169}} gab.com Text Anoctamin 2 identified as an autoimmune target in multiple sclerosis JO: Proc Natl Acad Sci U S A http://www.kidney.de/pget.php?&tw=1&pmid=26862169 #FOAvip Despite the growing evidence that autoantibodies are team players in the pathogenesis of multiple sclerosis (MS), the target autoantigens are yet to be identified. In this work, we mined the autoantibody repertoire within MS by screening more than 2,000 plasma samples from patients with MS and controls and identified increased autoantibody reactivity against an ion-channel protein called ?anoctamin 2? (ANO2). This finding points toward an ANO2 autoimmune sub-phenotype in MS and might contribute to the development of clinical algorithms to characterize a subgroup of MS patients. Twit Text FOAVip Anoctamin 2 identified as an autoimmune target in multiple sclerosis ????Proc Natl Acad Sci U S A http://www.kidney.de/pget.php?&tw=1&pmid=26862169 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26862169 #FOAvip English Wikipedia <ref>{{Cite pmid|26862169}}</ref> Anoctamin 2 identified as an autoimmune target in multiple sclerosis #MMPMID26862169 Ayoglu B; Mitsios N; Kockum I; Khademi M; Zandian A; Sjöberg R; Forsström B; Bredenberg J; Lima Bomfim I; Holmgren E; Grönlund H; Guerreiro-Cacais AO; Abdelmagid N; Uhlén M; Waterboer T; Alfredsson L; Mulder J; Schwenk JM; Olsson T; Nilsson P Proc Natl Acad Sci U S A 2016[Feb]; 113 (8): 2188-93 PMID26862169show ga Despite the growing evidence that autoantibodies are team players in the pathogenesis of multiple sclerosis (MS), the target autoantigens are yet to be identified. In this work, we mined the autoantibody repertoire within MS by screening more than 2,000 plasma samples from patients with MS and controls and identified increased autoantibody reactivity against an ion-channel protein called ?anoctamin 2? (ANO2). This finding points toward an ANO2 autoimmune sub-phenotype in MS and might contribute to the development of clinical algorithms to characterize a subgroup of MS patients. äAnoctamin 2 identified as an autoimmune target in multiple sclerosis (epmc).pdf DeepDyve Pubget Overpricing